Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude CE marks "less invasive" neurostimulation lead delivery system

This article was originally published in Clinica

Executive Summary

St Jude Medical has CE marked its Epiducer lead delivery system, used to implant neurostimulation devices, for sale in Europe. Neurostimulation therapy is used to manage chronic pain, and involves implantation of a paddle lead in the epidural space near the spine. Mild electrical impulses are delivered from a neurostimulator to the leads' electrodes, to interrupt or mask pain signals to the brain. The new system allows physicians to implant paddle leads through a single percutaneous entry point – previously, this had to be done via laminotomy, a more invasive surgical procedure in which part of the spine typically has to be removed. St Jude (St Paul, Minnesota) markets several neurostimulation systems, including Genesis and Eon Mini.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094812

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel